| For: |
Couvert P, Carrié A, Pariès J, Vaysse J, Miroglio A, Kerjean A, Nahon P, Chelly J, Trinchet JC, Beaugrand M, Ganne-Carrié N. Liver |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i35/5419.htm |
| Number | Citing Articles |
| 1 |
Yuhan Zhu, Lin Chen, Binyu Song, Zhiwei Cui, Guo Chen, Zhou Yu, Baoqiang Song. Insulin-like Growth Factor-2 (IGF-2) in Fibrosis. Biomolecules 2022; 12(11) doi: 10.3390/biom12111557
|
| 2 |
Kelly McDaniel, Chad Hall, Keisaku Sato, Terry Lairmore, Marco Marzioni, Shannon Glaser, Fanyin Meng, Gianfranco Alpini. Lin28 and let-7: roles and regulation in liver diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(10) doi: 10.1152/ajpgi.00080.2016
|
| 3 |
Xiaojuan Wu, Jinghong Liu. HBx-Associated Reactivation of the IGF2 Locus in Chronic HBV Infection and HBV-Related Hepatocarcinogenesis: Evidence Boundaries and Biomarker Implications. Biomedicines 2026; 14(7) doi: 10.3390/biomedicines14071440
|
| 4 |
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review). International Journal of Oncology 2012; 41(6) doi: 10.3892/ijo.2012.1666
|
| 5 |
|
| 6 |
Mónica Enguita-Germán, Puri Fortes. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World Journal of Hepatology 2014; 6(10): 716-737 doi: 10.4254/wjh.v6.i10.716
|
| 7 |
Philippe Couvert, Alain Carrié, Sophie Tezenas du Montcel, Jenny Vaysse, Angela Sutton, Nathalie Barget, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne, Philippe Giral, Jamel Chelly. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2012; 36(4) doi: 10.1016/j.clinre.2012.06.013
|
| 8 |
Takeshi Tomoda, Kazuhiro Nouso, Akiko Sakai, Mamoru Ouchida, Sayo Kobayashi, Koji Miyahara, Hideki Onishi, Shinichiro Nakamura, Kazuhide Yamamoto, Kenji Shimizu. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study. Journal of Gastroenterology and Hepatology 2012; 27(4) doi: 10.1111/j.1440-1746.2011.06948.x
|
| 9 |
Ahmed Ihab Abdelaziz, Gamal Esmat, Karim Adel Hosny, Injie Omar Fawzy, Hend Mohamed El Tayebi, Danira Ashraf Habashy. Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma. World Journal of Hepatology 2016; 8(23): 976-984 doi: 10.4254/wjh.v8.i23.976
|
| 10 |
Yasushi Adachi, Masanori Nojima, Mitsuru Mori, Ryogo Himori, Toshiyuki Kubo, Noriyuki Akutsu, Yingsong Lin, Youichi Kurozawa, Kenji Wakai, Akiko Tamakoshi. Insulin-Like Growth Factor 2 and Incidence of Liver Cancer in a Nested Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(11) doi: 10.1158/1055-9965.EPI-21-0481
|
| 11 |
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 2009; 51(4) doi: 10.1016/j.jhep.2009.05.008
|
| 12 |
Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adamek, Anna Gozdzicka-Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesis. Mutation Research/Reviews in Mutation Research 2017; 772 doi: 10.1016/j.mrrev.2016.08.007
|
| 13 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5) doi: 10.3390/ijms19051308
|
| 14 |
C. Nelson Hayes, Peiyi Zhang, Yizhou Zhang, Kazuaki Chayama. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses 2018; 10(10) doi: 10.3390/v10100531
|
| 15 |
|
| 16 |
Jing Qian, Dengfu Yao, Zhizhen Dong, Wei Wu, Liwei Qiu, Ninghua Yao, Shanshan Li, Yinzhu Bian, Zhiwei Wang, Gongsheng Shi. Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma. American Journal of Clinical Pathology 2010; 134(5) doi: 10.1309/AJCPTFDSE2V3LCZP
|
| 17 |
N A Wijetunga, M Pascual, J Tozour, F Delahaye, M Alani, M Adeyeye, A W Wolkoff, A Verma, J M Greally. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene 2017; 36(14) doi: 10.1038/onc.2016.340
|
| 18 |
Chang Zhang, Lei Shen, Wei Yuan, Yuguo Liu, Ruochen Guo, Yangjun Luo, Zheng Zhan, Zhiqin Xie, Guohao Wu, Wenwu Wu, Ying Feng. Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice. Communications Biology 2020; 3(1) doi: 10.1038/s42003-020-0893-5
|
| 19 |
Sonja M. Kessler, Stephan Laggai, Elien Van Wonterg, Katja Gemperlein, Rolf Müller, Johannes Haybaeck, Roosmarijn E. Vandenbroucke, Manfred Ogris, Claude Libert, Alexandra K. Kiemer. Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00147
|
| 20 |
Lysann Tietze, Sonja M. Kessler. The Good, the Bad, the Question–H19 in Hepatocellular Carcinoma. Cancers 2020; 12(5) doi: 10.3390/cancers12051261
|
| 21 |
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
|